row,column_idx,truth_value,llm_value,mismatch_value,llm_category
5,2,snrna-seq,rna-seq,6,6
6,2,scrna-seq,rna-seq,6,6
7,2,microarray,cgh,1,6
8,2,microarray,cgh,1,6
9,2,scrna-seq; vdj-seq,scrna-seq,5,5
10,2,scrna-seq; vdj-seq,sctcr-seq,6,6
10,4,kidney,"kidney, renal cell carcinoma",1,5
14,4,spleen,bone marrow,6,6
15,4,prostate,no,2,6
16,4,prostate,no,2,6
17,2,scrna-seq,rna-seq,1,6
18,2,scrna-seq,rna-seq,1,6
19,4,prostate cancer,prostate,1,3
20,4,prostate cancer,prostate,1,3
29,4,prostate,no,1,6
30,4,prostate,no,1,6
35,4,prostate carcinoma,prostate,3,3
36,4,prostate carcinoma,prostate,3,3
37,4,prostate carcinoma,prostate,3,3
38,4,prostate carcinoma,prostate,3,3
39,4,breast,breast tumor,2,4
40,4,breast,breast tumor,2,4
41,4,kidney,no,4,6
41,5,hek cells,hek-ter,4,4
42,4,kidney,no,4,6
42,5,hek cells,hek-ter,4,4
43,4,blood,bone marrow,6,6
44,4,blood,bone marrow,6,6
45,4,bone marrow,bone marrow microvascular niches (mvns),4,4
46,4,bone marrow,bone marrow microvascular niches (mvns),4,4
49,4,melanoma tumor sample/ skin?,melanoma single cell,3,3
50,4,melanoma tumor sample/ skin?,melanoma single cell,3,3
51,4,prostate,no,4,6
52,4,prostate,no,4,6
53,4,prostate,no,4,6
54,4,prostate,no,4,6
55,4,lung,no,1,6
56,4,lung,no,1,6
56,5,h1651,h1650,6,6
57,4,lymph nodes,draining lymph node,4,2
58,4,lymph nodes,draining lymph node,4,2
59,4,blood/ bone marrow,bone marrow,5,5
59,5,hoxb8 cell,hoxb8,2,4
60,4,blood/ bone marrow,bone marrow,5,5
60,5,hoxb8 cell,hoxb8,2,4
61,4,blood/ bone marrow,bone marrow,5,5
61,5,hoxb8 cell,hoxb8,6,4
62,4,blood/ bone marrow,bone marrow,5,5
62,5,hoxb8 cell,hoxb8,6,4
70,5,d459,d458,6,6
72,4,tumor inflitrating lymphocytes,blood,6,6
74,4,tumor inflitrating lymphocytes,blood,6,6
77,4,prostate,no,4,6
78,4,prostate,no,4,6
79,4,abdomen,abdominal wall tissue,4,4
80,2,scrna-seq,rna-seq,1,6
80,4,splenocytes and lymph nodes,lymphocytes,6,6
81,2,scrna-seq,rna-seq,1,6
81,4,splenocytes and lymph nodes,lymphocytes,6,6
82,4,prostate,no,1,6
82,5,myc-cap cells,myc-cap,2,2
83,4,prostate,no,1,6
83,5,myc-cap cells,myc-cap,2,2
84,4,prostate,no,1,6
85,4,prostate,no,1,6
85,5,tramp-c3,tramp-c2,1,6
86,4,prostate,no,1,6
86,5,myc-cap cells,myc-cap,2,2
87,4,prostate,no,1,6
87,5,myc-cap cells,myc-cap,2,2
88,4,prostate,pca cell line,1,6
88,5,myc-cap cells,myc-cap,2,2
89,4,prostate,pca cell line,1,6
89,5,myc-cap cells,myc-cap,2,2
90,4,prostate,no,1,6
90,5,lncap/ar,lncap/ar cells,1,2
91,4,prostate,no,1,6
91,5,lncap/ar,lncap/ar cells,1,2
92,4,lung,no,1,6
92,5,kp cells,kp lung tumor cells,2,2
93,4,lung,no,1,6
93,5,kp cells,kp lung tumor cells,2,2
94,3,mus musculus; synthetic construct,mus musculus,5,5
94,4,subcutaneously injected allograft tumor,no,3,6
94,5,,no,6,6
95,3,mus musculus; synthetic construct,mus musculus,5,5
95,4,subcutaneously injected allograft tumor,subcutaneously injected tumor,3,2
95,5,,no,6,6
96,4,prostate,no,1,6
96,5,lncap/ar,lncap/ar cells,1,2
97,4,prostate,no,4,6
97,5,lncap/ar,lncap/ar cells,1,2
98,2,shrna-seq,crispr-seq,1,6
98,3,synthetic construct; homo sapiens and murine mouse model,homo sapiens,5,3
98,4,prostate,no,1,6
98,5,lncap/ar cells utilized to induce tumor in scid mice,lncap/ar,3,2
99,2,shrna-seq,crispr-seq,1,6
99,3,synthetic construct; homo sapiens and murine mouse model,homo sapiens,5,3
99,4,prostate ,no,1,6
99,5,lncap/ar cells utilized to induce tumor in scid mice,lncap/ar,3,2
100,4,prostate,primary mouse prostate organoid culture,4,4
100,5,no. primary mouse prostate organoid culture,no,3,2
101,4,prostate,primary mouse prostate organoid culture,4,4
101,5,no. primary mouse prostate organoid culture,no,3,2
104,4,prostate,no,1,6
104,5,no/ xenograft,pc3,6,6
110,5,d458 cells,d458,2,2
111,5,d425 cells,d425,2,2
112,5,molm13 cells,molm13,2,2
113,5,molm13 cells,molm13,2,2
114,5,molm13 cells,molm13,2,2
115,5,molm13 cells,molm13,2,2
116,2,ribo-seq,ribosome profiling,1,2
117,2,ribo-seq,ribosome profiling,1,2
120,4,tumor infiltrating lymphocyte,blood,1,6
121,4,tumor infiltrating lymphocyte,blood,1,6
126,4,breast carcinoma,no,3,6
127,4,breast carcinoma,no,3,6
128,4,blood/plasma cell,bone marrow,6,6
129,4,multiple myeloma,bone marrow,6,6
133,2,scrna-seq,rna-seq,1,6
134,4,brain,hippocampus,4,4
135,4,brain,hippocampus,4,4
136,4,lung,lung tumor,4,3
136,5,no,kld-rna,1,6
137,4,lung,lung tumor,4,3
138,4,lung,lung tumor,4,3
139,4,lung,lung tumor,4,3
140,5,molm13 cells,molm13,2,2
148,4,lung,in vitro cultured cell line,6,6
148,5,kp cells,no,1,6
149,4,lung,no,1,6
149,5,h2009 cells,h2009,2,2
150,4,prostate,no,6,6
150,5,lncap-ai (androgen independent),lncap-ai,2,2
151,4,prostate,no,6,6
151,5,du145 cells,du145,2,2
152,4,prostate,normal prostate,6,4
153,4,prostate,normal prostate,6,4
154,4,prostate,no,1,6
154,5,pc3 cells,pc3,2,2
155,5,pc3 cells,pc3,2,2
156,4,prostate,prostate epithelium-derived cells,4,4
157,4,prostate,prostate epithelium-derived cells,4,4
158,4,skin,melanoma allograft,1,4
158,5,m3 cell line derived mouse allograft,m3 cell line,6,2
159,4,skin,melanoma allograft,1,4
159,5,m3 cell line derived mouse allograft,m3 cell line,3,2
166,4,ovary,ovarian cancer cell line (ovcar3),4,4
166,5,ocvar3 cells,ovcar3,2,2
167,5,ocvar3 cells,ovcar3,2,2
170,4,blood,monocyte-derived macrophages,6,6
171,4,blood,monocyte-derived macrophages,6,6
172,4,breast,breast tumor,4,4
173,4,breast,breast tumor,4,4
174,4,lymph nodes,draining ln,4,2
175,4,lymph nodes,lymph node,1,2
177,5,lncap,lncap-rb1/tp53 double knockout human prostate tumor cell line,4,4
179,4,large intestine,colon,6,2
182,4,bone marrow aspirates,bone marrow,3,3
183,4,bone marrow aspirates,bone marrow,3,3
184,2,plumage,5’ utr mutational analysis,6,6
184,4,kidney,"kidney, embryonic",1,5
184,5,hek293 t,hek293t,2,2
185,2,plumage,5’ utr mutational analysis,6,6
185,4,kidney,"kidney, embryonic",1,5
185,5,hek293 t,hek293t,2,2
186,4,esophagus,adjacent normal esophageal tissue,4,4
187,4,esophagus,esophageal squamouse carcinoma,4,4
188,4,esophagus,esophageal squamouse carcinoma,4,4
189,4,esophagus,adjacent normal esophageal tissue,4,4
190,2,cite-seq,sctcr-seq,6,6
191,2,cite-seq,sctcr-seq,6,6
192,4,umbilical vein endothelium,blood vessel,6,3
193,4,umbilical vein endothelium,blood vessel,6,3
194,4,unclear,cd8+cd3+ tumor infiltrating cells,6,6
195,4,unclear,cd8+cd3+ tumor infiltrating cells,6,6
196,4,esophagus,immortalized normal esophageal epithelium,4,4
197,4,esophagus,esophageal squamous carcinoma,4,4
197,5,ec-109,no,6,6
198,4,umbilical vein endothelium,blood vessel,6,3
199,4,umbilical vein endothelium,blood vessel,6,3
202,4,mouth/ oral cavity,tumor,6,3
202,5,moc1,no,6,6
203,4,mouth/ oral cavity,tumor,6,3
203,5,moc1,no,6,6
210,4,sub cutaneous tumors (xenograft),cd45+ tumor infiltrating cells,6,6
211,4,sub cutaneous tumors (xenograft),cd45+ tumor infiltrating cells,6,6
214,4,breast,breast tumor,4,4
215,4,breast,breast tumor,4,4
216,2,"scbcr-seq
          ",scrna-seq,6,6
217,2,"scbcr-seq
          ",scrna-seq,6,6
218,2,scrna-seq,rna-seq,1,6
219,2,scrna-seq,rna-seq,1,6
223,5,oci-aml2 cells,oci-aml2,2,2
224,5,oci-aml2 cells,oci-aml2,2,2
225,4,lung,no,4,6
225,5,hci- h69,nci-h69,3,6
226,4,lung,no,4,6
227,2,microarray,methylation profiling by array,1,2
228,2,microarray,methylation profiling by array,1,2
229,2,clint-seq  (mrna sequencing via crosslinker regulated intracellular phenotype),clint-seq,6,2
230,2,clint-seq  (mrna sequencing via crosslinker regulated intracellular phenotype),clint-seq,6,2
233,4,pancreas,no,4,6
234,4,pancreas,no,4,6
235,2,scrna-seq,target site sequencing,1,6
236,2,scrna-seq,target site capture,1,6
247,4,soft tissue/ bone,no,6,6
248,4,soft tissue/ bone,soft-tissue sarcoma cells,4,4
249,4,soft tissue/ bone,immune-enriched cells from 8 mouse subcutaneous tumors,6,6
250,4,soft tissue/ bone,immune-enriched cells from 8 mouse subcutaneous tumors,6,6
253,4,breast,no,1,6
254,4,breast,no,1,6
257,4,intestine,colon,4,2
258,4,intestine,proximal small intestine,4,4
259,4,intestine,no,4,6
260,4,intestine,no,4,6
262,4,prostate,no,1,6
265,4,prostate,no,1,6
266,4,prostate,no,1,6
267,4,prostate,no,1,6
268,4,prostate,no,1,6
269,4,prostate,no,1,6
270,4,prostate,no,1,6
271,2,rna-seq/ plumage,rna-seq,5,5
275,4,lymph nodes,mantle cell lymphoma patient derived xenograft,6,4
275,5,no,mcl96069,6,6
276,4,lymph nodes,mantle cell lymphoma patient derived xenograft,6,4
276,5,no,mcl96069,6,6
277,4,prostate,prostate epithelial cell line,4,4
278,4,prostate,prostate epithelial cell line,4,4
279,2,bisulfite-seq/ methyl-capture,methyl capture,5,2
279,4,prostate,no,4,6
280,2,bisulfite-seq/ methyl-capture,methyl capture,5,2
280,4,prostate,no,4,6
281,4,prostate,no,4,6
282,4,prostate,no,4,6
283,2,exome-seq,5’ utr capture-seq,6,6
283,5,pdx derived from lucap series 23 cells,no,6,6
284,2,exome-seq,5’ utr capture-seq,6,6
284,5,pdx derived from lucap series 23 cells,no,6,6
287,4,intestine,intestinal tissue,2,2
288,4,intestine,intestinal tissue,2,2
289,2,crispr-seq,crispr screen,1,6
290,2,crispr-seq,crispr screen,1,6
292,5,387,cw 387,2,2
297,4,blood,whole blood,4,2
298,4,blood,whole blood,4,2
299,2,microarray,epic,1,6
299,4,prostate,no,1,6
300,2,microarray,epic,1,6
300,4,prostate,genomic dna from cell line,1,6
301,2,microarray,epic,1,6
301,4,prostate xenograft,genomic dna from xenograft tissue,3,6
301,5,primary xenograft cwr22,cwr22,3,3
302,2,microarray,methylation profiling by array,1,2
302,4,prostate xenograft,genomic dna from xenograft tissue,3,6
302,5,primary xenograft cwr22,cwr22,3,3
303,4,prostate xenograft,cwr22 xenograft,3,2
303,5,primary xenograft cwr22,no,3,6
304,4,prostate xenograft,cwr22 xenograft,3,2
304,5,primary xenograft cwr22,no,3,6
305,4,peripheral nervous system,no,4,6
305,5,suz12 isogenic m3 mpnst cells,m3 mpnst cells,3,3
306,4,peripheral nervous system,no,4,6
306,5,suz12 isogenic m3 mpnst cells,m3 mpnst cells,3,3
307,4,peripheral nervous system,no,4,6
307,5,suz12 isogenic m3 mpnst cells,m3 mpnst cells,3,3
308,4,peripheral nervous system,no,4,6
308,5,suz12 isogenic m3 mpnst cells,m3 mpnst cells,3,3
309,2,bisulfite-seq,methyl-seq,1,2
309,4,peripheral nervous system,no,4,6
309,5,suz12 isogenic m3 mpnst cells,m3 mpnst cells,3,3
310,2,bisulfite-seq,methyl-seq,1,2
310,4,peripheral nervous system,no,4,6
310,5,suz12 isogenic m3 mpnst cells,m3 mpnst cells,3,3
311,4,lung,primary lung tumor,4,2
312,4,lung,primary lung tumor,4,2
313,4,prostate,no,1,6
313,5,lncap-c42 (ar therapy resistant),lncap-c42,3,2
314,4,prostate,no,1,6
314,5,lncap-c42 (ar therapy resistant),lncap-c42,3,2
315,4,prostate,no,1,6
315,5,lncap-c42 (ar therapy resistant),lncap-c42,3,2
316,4,prostate,no,1,6
316,5,lncap-c42 (ar therapy resistant),lncap,3,4
317,4,blood/ spleen,blood,5,5
318,4,breast,no,1,6
319,4,prostate,no,1,6
320,4,skin,merkel cell carcinoma,1,4
320,5,waga cells,waga,2,2
321,4,skin,merkel cell carcinoma,1,4
321,5,waga cells,waga,2,2
322,4,skin,merkel cell carcinoma,1,4
323,4,skin,merkel cell carcinoma,1,4
324,4,skin,merkel cell carcinoma,1,4
325,4,skin,merkel cell carcinoma,1,4
328,4,pancreas,pancrease,4,2
328,5,aspc1,aspc-1,2,2
329,4,pancreas,pancrease,4,2
329,5,aspc1,aspc-1,2,2
330,2,rna-seq; scrna-seq; atac-seq; cut&tag; cut&run,chip-seq,6,6
330,5,kasumi-1 cells,kasumi-1,2,2
331,2,rna-seq; scrna-seq; atac-seq; cut&tag; cut&run,rna-seq,5,5
331,5,no,14-00613,6,6
334,4,prostate,brain,1,6
335,4,prostate,brain,1,6
336,4,small intestine,small intestinal stromal cells,1,4
337,4,colon/ large intestine,colon,5,2
338,4,colon/ large intestine,colonic stromal cells,5,4
339,4,colon/ large intestine,colon,5,2
345,2,rna-seq;,rna-seq,2,2
346,4,blood,bone marrow,1,6
346,5,kasumi-1 cells,kasumi-1,2,2
347,5,kasumi-1 cells,kasumi-1,2,2
348,4,bladder xenograft,bladder,4,3
348,5,no,t24,6,6
349,4,bladder xenograft,bladder,3,3
349,5,no,t24,6,6
350,4,lung,no,1,6
351,4,lung,no,1,6
352,4,intestine,intestinal stem cells and progenitor cells,4,4
353,4,intestine,intestinal stem cells and progenitor cells,4,4
355,2,scrna-seq; scatac-seq,scrna-seq,5,5
356,4,prostate/ bone metastasis,no,5,6
356,5,pc3e (pc3 cells sorted for e-cadherin-positive cells ),pc3e,1,2
360,5,no/ induced pluripotent cells,no,5,6
361,5,no/ induced pluripotent cells,no,5,6
364,4,prostate xenograft,prostate tumor,4,2
365,4,prostate xenograft,prostate,4,3
368,2,cite-seq,sctcr-seq,6,6
369,2,cite-seq,sctcr-seq,6,6
374,4,prostate,no,4,6
375,4,prostate,no,4,6
378,4,blood,peripheral blood,4,2
379,4,blood,peripheral blood,4,2
382,4,prostate,no,1,6
383,4,prostate,no,1,6
384,4,prostate,no,1,6
385,4,prostate,no,1,6
386,4,prostate,no,4,6
387,4,prostate,no,4,6
392,4,bladder,bladder tumor,4,4
393,4,bladder,bladder tumor,4,4
396,4,spleen,no,6,6
397,4,spleen,no,3,6
404,5,mouse lung squamous cell carcinoma cell line,p2d,2,6
405,5,mouse lung squamous cell carcinoma cell line,lung squamous cell carcinoma cell line,2,2
408,4,breast,no,1,6
409,4,breast,no,1,6
410,5,no,lucap 78,6,6
411,5,no,lucap 77,6,6
412,4,breast,no,1,6
413,4,breast,no,1,6
414,4,pancrease,no,4,6
415,4,pancrease,no,4,6
416,4,human glioblastoma pdx models,brain,3,3
417,4,human glioblastoma pdx models,brain,3,3
418,4,liver,liver tumor biopsy,4,4
419,2,cite-seq,scrna-seq,6,6
421,4,subcutaneous tumor tissue (flank),tumor,3,3
422,4,subcutaneous tumor tissue (flank),tumor,3,3
433,4,prostate,gemm,6,6
434,4,prostate,metastatic crpc,1,4
435,4,subcutaneous tumor,s.c. tumor,2,2
435,5,mc38,no,6,6
436,4,subcutaneous tumor,s.c. tumor,2,2
436,5,mc38,no,6,6
437,4,blood,peripheral blood mononuclear cells,4,4
438,4,blood,peripheral blood mononuclear cells,4,4
439,4,blood / bone marrow,blood,5,5
440,4,blood / bone marrow,blood,5,5
441,4,breast,no,1,6
442,4,breast,no,1,6
443,4,breast,no,1,6
444,4,breast,no,1,6
447,4,breast,no,1,6
448,4,breast,no,1,6
453,2,tequila-seq,rna-seq,1,6
454,2,tequila-seq,rna-seq,1,6
454,4,breast,breast cancer,4,4
463,4,blood,whole blood,4,2
464,4,blood,whole blood,4,2
465,2,crispr-cas9 sgrna screen,crispr-seq,3,6
467,4,breast,breast cancer cells,4,4
469,2,scbs-seq,scbisulfite-seq,1,2
470,2,scbs-seq,scbisulfite-seq,1,2
475,4,peritoneal fluid,blood,6,6
476,4,peritoneal fluid,blood,6,6
477,4,prostate,no,1,6
478,4,prostate,no,4,6
478,5,lncap-n-myc,lncap,1,4
479,2,microarray,methylation profiling by array,1,2
480,2,microarray,methylation profiling by array,1,2
481,4,bone marrow,blood,1,6
482,4,bone marrow,blood,1,6
483,4,breast,breast tumor,1,4
483,5,pymt,no,6,6
484,4,breast,breast tumor,1,4
484,5,pymt,no,6,6
485,2,cite-seq,sctcr-seq,6,6
485,4,brain,pediatric brain tumor,1,4
486,2,cite-seq,sctcr-seq,6,6
486,4,brain,pediatric brain tumor,1,4
487,4,breast,epithelial breast,1,4
488,4,breast,epithelial breast,1,4
491,4,in vivo tumor-derived akp organoid,no,1,6
491,5,no,in vivo tumor-derived akp organoid,1,6
492,4,in vivo tumor-derived akp organoid,no,1,6
492,5,no,in vivo tumor-derived akp organoid,1,6
493,4,colon tumor,colon,3,3
494,4,colon tumor,colon,3,3
497,4,prostate ,no,1,6
498,4,prostate ,no,4,6
499,4,kidney,renal cell carcinoma,4,4
500,4,kidney,renal cell carcinoma,4,4
502,4,kidney,renal cell carcinoma,4,4
505,4,tubular adenoma,colon,3,3
506,4,tubular adenoma,colon,3,3
509,4,bone marrow,bone marrow cells,2,4
510,4,bone marrow,bone marrow cells,2,4
511,4,tongue epithelium,no,6,6
512,4,tongue epithelium,no,6,6
513,4,bone marrow,bone marrow cells,1,4
514,4,bone marrow,bone marrow cells,1,4
521,4,breast,breast tumor,4,4
522,4,breast,breast tumor,4,4
523,4,breast,mammary fibroblasts,1,6
523,5,primary mouse mammary fibroblasts ,primary mouse mammary fibroblasts line,2,2
524,4,breast,mammary fibroblasts,1,6
524,5,primary mouse mammary fibroblasts,primary mouse mammary fibroblasts line,2,2
525,4,breast,mammary fat pad,4,6
526,4,breast,mammary fat pad,4,6
533,4,skin,solid tumor,6,6
534,4,skin,solid tumors,6,3
535,4,skin,solid tumors,6,3
536,2, crispr screen,crispr-seq,6,2
536,5,trametinib resistant molm13,molm-13,3,2
537,2,crispr screen,crispr-seq,6,2
537,5,trametinib resistant molm13,molm-13,3,2
538,4,prostate,no,1,6
539,4,prostate,no,1,6
540,4,bone marrow,bone marrow plasma cells,4,4
541,4,bone marrow,bone marrow plasma cells,4,4
542,4,bone marrow,primary dendritic cells,6,6
543,4,bone marrow,primary dendritic cells,6,6
544,4,bone marrow,primary dendritic cells,6,6
545,4,bone marrow,primary dendritic cells,6,6
546,4,pancreas,pancreatic tumor,4,4
547,4,pancreas,pancreatic tumor,4,4
550,4,in vitro–differentiated cd8⁺ t cells from hpscs,blood,6,6
550,5,"esi017 tko8 eso hpsc (rag1/rag2/b2m triple knockout, tcr-transduced)",no,6,6
551,4,in vitro–differentiated cd8⁺ t cells from hpscs,blood,6,6
551,5,esi017 wt hpsc,no,6,6
574,4,skin,tumor,1,3
575,4,colon,tumor,4,3
576,4,embryo,mef+sv40,4,6
576,5,mef+sv40,no,1,6
577,4,embryo,mef+sv40,4,6
577,5,mef+sv40,no,1,6
598,4,lung,no,1,6
605,4,prostate,tissue,6,3
606,4,prostate,tissue,6,3
611,4,tongue,no,6,6
612,4,tongue,no,3,6
613,4,head and neck,tumor,3,3
614,4,head and neck,tumor,3,3
617,4,kidney,"kidney, renal clear cell carcinoma",1,5
618,4,kidney,"kidney, renal clear cell carcinoma",1,5
619,4,kidney,"kidney, renal clear cell carcinoma",1,5
620,4,kidney,"kidney, renal clear cell carcinoma",1,5
621,4,kidney,"kidney, renal clear cell carcinoma",1,5
622,4,kidney,"kidney, renal clear cell carcinoma",1,5
623,4,kidney,"kidney, renal clear cell carcinoma",1,5
624,4,kidney,"kidney, renal clear cell carcinoma",1,5
625,4,kidney,"kidney, renal clear cell carcinoma",1,5
626,4,kidney,"kidney, renal clear cell carcinoma",1,5
627,4,kidney,"kidney, renal clear cell carcinoma",1,5
628,4, ,"kidney, renal clear cell carcinoma",6,5
629,4,prostate,prostate tumor,4,4
630,4,prostate,prostate tumor,4,4
631,4,prostate,myc-cap tumor,1,6
631,5,myc-cap,no,6,6
632,4,prostate,myc-cap tumor,1,6
633,4,prostate organoid,mouse prostate organoid,4,4
634,4,prostate organoid,mouse prostate organoid,4,4
637,4,bone marrow,blood,1,6
641,4,breast,breast cancer tissue,4,4
642,4,breast,breast cancer tissue,4,4
645,4,prostate,"prostate tumor, lymph node",5,5
646,4,prostate,"prostate tumor, primary",5,4
651,3,homo sapiens,mus musculus,1,6
651,4,lymph node ,lymph node metastasis,4,4
652,3,homo sapiens,mus musculus,1,6
657,2,crispr screen,crispr-seq,6,2
657,4,soft tissue,synovial sarcoma,4,4
658,2,crispr screen,crispr-seq,6,6
658,4,soft tissue,synovial sarcoma,4,4
659,4,soft tissue,no,4,6
660,4,soft tissue,no,4,6
661,4,soft tissue,synovial sarcoma,4,4
662,4,soft tissue,synovial sarcoma,4,4
663,4,soft tissue,synovial sarcoma,4,4
664,4,soft tissue,synovial sarcoma,4,4
665,4,bone marrow,human bone marrow biopsy,4,4
666,4,bone marrow,human bone marrow biopsy,1,4
667,5,n1_4172,n4172,1,2
668,5,n6_4172,no,6,6
669,2,cut&tag,cut&tag-seq,2,2
669,5,ey,no,6,6
670,2,cut&tag,cut&tag-seq,2,2
670,5,ey,no,6,6
671,4,tongue epithelium,tongue epithelium primary culture,1,4
671,5,eyh2_4028,no,6,6
672,5,n2_4172,no,6,6
673,4,tongue?,tongue epithelium,4,4
677,4,pancreas,primary pancreatic ductal adenocarcinoma,4,4
678,4,pancreas,primary pancreatic ductal adenocarcinoma,4,4
680,4,breast,no,1,6
684,2,scrna-seq,scmultiome,6,6
687,4,lung,lung adenocarcinoma,4,4
688,4,lung,lung adenocarcinoma,4,4
691,4,breast,ffpe,6,6
692,4,breast,ffpe,6,6
693,4,kidney,embryonic kidney,4,4
694,4,kidney,embryonic kidney,4,4
701,4,gastrointestinal tract,no,4,6
702,4,gastrointestinal tract,no,4,6
707,4,skin,no,1,6
708,4,skin,no,1,6
710,4,prostate,no,4,6
711,4,prostate,no,4,6
712,4,prostate,no,4,6
713,4,prostate,no,4,6
714,4,prostate,no,4,6
715,4,prostate,no,1,6
716,4,prostate,no,1,6
718,4,prostate,no,4,6
719,4,prostate,no,1,6
721,4,intestine,intestinal stem cells,1,4
722,4,intestine,intestinal stem cells,1,4
724,4,prostate,primary tumor castrate recurrent,1,6
725,2,qrt-pcr array,microarray,3,6
725,5,tramp-c2,no,6,6
726,2,qrt-pcr array,microarray,3,6
726,5,tramp-c2,no,6,6
727,4,lung,non-small cell lung cancer cells,4,4
728,4,lung,non-small cell lung cancer cells,4,4
729,4,lung,non-small cell lung cancer cells,4,4
730,4,lung,non-small cell lung cancer cells,4,4
732,4,lung,no,1,6
735,4,prostate,no,4,6
735,5,lncap-apipc,lncap-apipc human prostate tumor cell line,1,4
736,4,prostate,no,4,6
736,5,lncap-shar/patk,lncap-shar/patk  human prostate tumor cell line,1,2
